Back to search

Article

An integrated <i>in silico</i> immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets

2020-05-13

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has a major global health and socio-economic burden. It has instigated the mobilisation of resources into the development of control tools, such as diagnostics and vaccines. The poor performance of some diagnostic serological tools has emphasised the need for up to date immune-informatic analyses to inform the selection...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e7607eb6-0ee6-5d7b-b929-8273d0ac6229
DOI
10.1101/2020.05.11.089409
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An integrated <i>in silico</i> immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targetsDOI 10.1101/2020.05.11.089409
An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.Semantic proximity
Design of a Companion Bioinformatic Tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variantsSemantic proximity
Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.Semantic proximity
Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.Semantic proximity
Bioinformatic analysis of B and T cell epitopes from SARS-CoV-2 Spike, Membrane and Nucleocapsid proteins as a strategy to assess possible cross-reactivity between emerging variants, including Omicron, and other human coronavirusesSemantic proximity
Integrating Machine Learning-Enhanced Immunopeptidomics and SARS-CoV-2 Population-Scale Analyses Unveils Novel Antigenic Features for Next-Generation COVID-19 VaccinesSemantic proximity
Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses.Semantic proximity
ESC - a comprehensive resource for SARS-CoV-2 immune escape variantsSemantic proximity
Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine TargetsSemantic proximity
Early Detection of Emerging SARS-CoV-2 Variants of Interest for Experimental EvaluationSemantic proximity
Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variantsSemantic proximity
Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine DevelopmentSemantic proximity
Select a neighboring publication to make it the new centre.